Guozhi Tang

1.4k total citations
30 papers, 1.0k citations indexed

About

Guozhi Tang is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Guozhi Tang has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Epidemiology and 6 papers in Organic Chemistry. Recurrent topics in Guozhi Tang's work include Chemical Synthesis and Analysis (5 papers), Cell death mechanisms and regulation (4 papers) and Protein Degradation and Inhibitors (4 papers). Guozhi Tang is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Cell death mechanisms and regulation (4 papers) and Protein Degradation and Inhibitors (4 papers). Guozhi Tang collaborates with scholars based in China, United States and Switzerland. Guozhi Tang's co-authors include Chao‐Yie Yang, Shaomeng Wang, Su Qiu, Zaneta Nikolovska‐Coleska, Jeanne A. Stuckey, Sheng Jiang, Peter P. Roller, Wei Gao, Renxiao Wang and Krzysztof Krajewski and has published in prestigious journals such as Advanced Materials, PLoS ONE and Cancer Research.

In The Last Decade

Guozhi Tang

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guozhi Tang China 18 533 258 242 149 100 30 1.0k
Christian Gege Germany 23 665 1.2× 146 0.6× 353 1.5× 282 1.9× 60 0.6× 60 1.4k
Todd W. Rockway United States 20 387 0.7× 102 0.4× 237 1.0× 159 1.1× 162 1.6× 38 940
Junko Ohkanda Japan 24 1.2k 2.3× 239 0.9× 503 2.1× 421 2.8× 125 1.3× 79 1.9k
Maria Bretner Poland 25 1.1k 2.0× 125 0.5× 630 2.6× 196 1.3× 128 1.3× 82 1.9k
Philip S. Jones United Kingdom 24 505 0.9× 72 0.3× 883 3.6× 135 0.9× 98 1.0× 63 1.7k
Amartya Basu United States 23 457 0.9× 104 0.4× 439 1.8× 165 1.1× 166 1.7× 40 1.2k
Beat Weidmann Switzerland 18 533 1.0× 106 0.4× 879 3.6× 141 0.9× 82 0.8× 25 1.3k
Suzanne Peyrottes France 22 737 1.4× 178 0.7× 505 2.1× 130 0.9× 36 0.4× 94 1.5k
Girija Krishnamurthy United States 18 432 0.8× 85 0.3× 355 1.5× 68 0.5× 45 0.5× 30 867
Daniela Fattori Italy 16 935 1.8× 70 0.3× 712 2.9× 259 1.7× 124 1.2× 46 1.4k

Countries citing papers authored by Guozhi Tang

Since Specialization
Citations

This map shows the geographic impact of Guozhi Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guozhi Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guozhi Tang more than expected).

Fields of papers citing papers by Guozhi Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guozhi Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guozhi Tang. The network helps show where Guozhi Tang may publish in the future.

Co-authorship network of co-authors of Guozhi Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Guozhi Tang. A scholar is included among the top collaborators of Guozhi Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guozhi Tang. Guozhi Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vijenthira, Abi, Andrew S. Wilton, Seung Hoo Lee, et al.. (2024). Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?. British Journal of Haematology. 205(3). 1126–1136.
2.
3.
Lin, Xianfeng, Weixing Zhang, Zongxing Qiu, et al.. (2019). A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles. Journal of Medicinal Chemistry. 62(22). 10352–10361. 7 indexed citations
4.
Zhou, Zheng, Taishan Hu, Xue Zhou, et al.. (2017). Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms. Scientific Reports. 7(1). 42374–42374. 117 indexed citations
5.
Xu, Danqing, Zhiheng Xu, Li Han, et al.. (2016). Identification of New ATG4B Inhibitors Based on a Novel High-Throughput Screening Platform. SLAS DISCOVERY. 22(4). 338–347. 27 indexed citations
6.
Qiu, Zongxing, Bernd Kuhn, Johannes D. Aebi, et al.. (2016). Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors. ACS Medicinal Chemistry Letters. 7(8). 802–806. 55 indexed citations
7.
Lin, Xianfeng, Wen-Ming Chen, Zongxing Qiu, et al.. (2015). Design and Synthesis of Orally Bioavailable Aminopyrrolidinone Histone Deacetylase 6 Inhibitors. Journal of Medicinal Chemistry. 58(6). 2809–2820. 37 indexed citations
8.
Tang, Guozhi, Xianfeng Lin, Zongxing Qiu, et al.. (2011). Design and Synthesis of Benzenesulfonamide Derivatives as Potent Anti-Influenza Hemagglutinin Inhibitors. ACS Medicinal Chemistry Letters. 2(8). 603–607. 29 indexed citations
9.
Zhu, Lei, Yuhuan Li, Shaohua Li, et al.. (2011). Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin. PLoS ONE. 6(12). e29120–e29120. 47 indexed citations
10.
Tang, Guozhi, Zongxing Qiu, Xianfeng Lin, et al.. (2010). Discovery of novel 1-phenyl-cycloalkane carbamides as potent and selective influenza fusion inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(12). 3507–3510. 13 indexed citations
11.
Tang, Guozhi, D Kertesz, Minmin Yang, et al.. (2010). Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses. Bioorganic & Medicinal Chemistry Letters. 20(20). 6020–6023. 31 indexed citations
12.
Yu, Rujia, Kehan Yu, Wei Wang, et al.. (2007). Nd2O3 Nanoparticles Modified with a Silane‐Coupling Agent as a Liquid Laser Medium. Advanced Materials. 19(6). 838–842. 66 indexed citations
13.
Tang, Guozhi, Chao‐Yie Yang, Zaneta Nikolovska‐Coleska, et al.. (2007). Pyrogallol-Based Molecules as Potent Inhibitors of the Antiapoptotic Bcl-2 Proteins. Journal of Medicinal Chemistry. 50(8). 1723–1726. 42 indexed citations
14.
Peng, Bo, Xiaoming Qiu, Lei Jiang, et al.. (2005). A Novel Transparent Vanadate Glass for Use in Fiber Optics. Advanced Materials. 17(7). 857–859. 47 indexed citations
15.
Tang, Guozhi, Hongqi Tian, & Dawei Ma. (2004). Asymmetric Strecker reaction of γ-keto acids. Facile entry to α-substituted and α,γ-disubstituted glutamic acids. Tetrahedron. 60(46). 10547–10552. 19 indexed citations
16.
Tang, Guozhi, et al.. (2002). Synthesis and Mesomorphic Properties of Some Fluorinated Benzoate Liquid Crystals. Molecular Crystals and Liquid Crystals. 373(1). 1–15. 7 indexed citations
17.
Wang, Yi, et al.. (2001). An improved enantioselective synthesis of no‐carrier‐added (NCA) 6‐[18F]FLUORO‐L‐DOPA. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 2 indexed citations
18.
Tang, Guozhi, et al.. (2001). [Synthesis and determination for enantiomeric purity of 6-fluoro-L-DOPA].. PubMed. 36(10). 739–42. 1 indexed citations
19.
Ma, Dawei, et al.. (1999). Enantioselective syntheses of α-substituted glutamic acids and α,γ-disubstituted glutamic acids by an asymmetric Strecker reaction. Tetrahedron Letters. 40(31). 5753–5756. 10 indexed citations
20.
Lin, Ling, et al.. (1996). Nerve growth factors prevent glutamate toxicity in cortical neuronal cultures.. PubMed. 17(3). 221–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Gege Breakdown of academic impact, for papers by Todd W. Rockway Breakdown of academic impact, for papers by Junko Ohkanda Breakdown of academic impact, for papers by Maria Bretner Breakdown of academic impact, for papers by Philip S. Jones Breakdown of academic impact, for papers by Amartya Basu Breakdown of academic impact, for papers by Beat Weidmann Breakdown of academic impact, for papers by Suzanne Peyrottes Breakdown of academic impact, for papers by Girija Krishnamurthy Breakdown of academic impact, for papers by Daniela Fattori
Rankless by CCL
2026